Mykare Raises US$1M Bridge Round to Expand AI Healthcare Platform Globally

Mykare Co-Founders: Joash Philipose (CPO), Rahmathulla TM(CTO), and Senu Sam (CEO)

Indian healthtech startup Mykare has secured an additional US$1 million in bridge funding, increasing its total funding to US$3.2 million since its founding in 2022. The round was led by Andrew Parker and Alfredo Vaamonde, co-founders of US-based healthtech company Papa.com, alongside participation from a Middle Eastern family office.

The latest investment will support Mykare's expansion of its AI-powered healthcare platform while strengthening its presence across India, the United States, the United Kingdom, and the Middle East. The funding also reflects growing investor confidence in AI-driven healthcare infrastructure, a sector expected to reach US$37 billion in India by 2030.

Why Did Mykare Raise Another US$1 Million?

The bridge round will primarily be used to accelerate Mykare's product roadmap and expand its proprietary artificial intelligence capabilities.

The company plans to invest in:

• Enhancing its AI-native healthcare operating system
• Accelerating product development cycles
• Expanding into additional international healthcare networks
• Growing partnerships with hospitals and multi-clinic operators
• Scaling AI automation across patient engagement workflows

The funding follows Mykare's US$2.2 million Seed round in 2023, backed by investors including OnDeck ODX and Avaana Seed, bringing total funding to US$3.2 million.

The participation of founders from Papa.com, together with a Middle Eastern family office, highlights increasing cross-border investment into healthcare AI solutions. The Middle East has become an increasingly active destination for healthtech investment, supported by innovation ecosystems including Hub71, ADGM, NEOM Health, and regional family offices seeking AI-enabled healthcare opportunities.

How Does Mykare's AI Healthcare Operating System Work?

Rather than offering standalone AI tools, Mykare is building an AI-native healthcare operating system (OS) that automates the patient journey from discovery to long-term engagement.

Its platform is designed to reduce administrative workloads while improving patient experience across hospitals and clinics.

Key platform capabilities include:

AI Capability	Business Impact
AI voice agents	Answer patient calls and identify patient intent automatically
Appointment automation	Schedule and manage bookings with minimal staff intervention
CRM integration	Update patient records automatically after interactions
Patient acquisition	Improve lead conversion and onboarding
Feedback & retention	Collect reviews and encourage repeat visits

The automation enables healthcare providers to reduce manual administrative work while allowing clinical teams to focus more on patient care.

How Widely Has Mykare Been Adopted?

The company reports strong early traction across multiple healthcare markets.

Current deployment metrics

Metric	Current Status
Total funding	US$3.2 million
Bridge round	US$1 million (2026)
Seed funding	US$2.2 million (2023)
Hospitals using AI platform	30–35
Additional clinics signed	45
Short-term expansion goal	100 clinics
Waiting list	20+ hospitals and providers

According to co-founder Senu Sam, Mykare aims to expand its AI platform to 100 healthcare facilities in the near term, reflecting strong market demand for workflow automation and patient engagement technologies.

Which Markets Is Mykare Expanding Into?

Founded in 2022 by Senu Sam, Rahmatulla TM, and Joash Philipose, Mykare has rapidly expanded beyond India into multiple international healthcare markets.

Today, the company operates across:

• India
• United States
• United Kingdom
• Middle East

Within India, Mykare maintains a strong presence across major metropolitan cities while simultaneously building partnerships with international healthcare providers.

The company has already partnered with:

• A major oncology clinic chain in the United States
• A leading dental chain in the United Kingdom
• A large dental network in Qatar (currently under advanced discussions)

These partnerships support Mykare's broader strategy of creating an interconnected global provider network powered by AI.

Why Is AI Healthcare Attracting Investors?

Mykare's latest funding reflects broader momentum across the global digital health sector.

India's healthtech industry is projected to become a US$37 billion market by 2030, driven by increasing adoption of AI-powered diagnostics, preventive healthcare, workflow automation, and digital patient engagement platforms.

Across the Middle East, governments and innovation hubs—including Hub71, ADGM, and NEOM—continue to prioritize healthcare innovation as part of wider digital transformation agendas. This has increased regional interest in startups developing scalable AI infrastructure for hospitals, clinics, and healthcare providers.

Against this backdrop, Mykare is positioning itself as an infrastructure platform rather than simply another healthcare application, giving it opportunities to scale across multiple healthcare systems.

What Does Mykare's Latest Funding Mean?

The additional US$1 million bridge round strengthens Mykare's ability to expand both technologically and geographically.

With US$3.2 million raised to date, deployments across more than 30 healthcare facilities, 45 additional clinics awaiting implementation, and expansion plans targeting 100 clinics, the company is building one of the more ambitious AI-enabled healthcare operating platforms emerging from India.

Backed by experienced healthtech founders, international investors, and Middle Eastern capital, Mykare is well positioned to capitalize on the continued growth of AI-powered healthcare infrastructure across India, the US, the UK, and the Middle East.

 

 

FAQ

1. How much funding has Mykare raised?
Mykare has raised a total of US$3.2 million, including a US$1 million bridge round and a US$2.2 million Seed round completed in 2023.

2. Who invested in Mykare's latest funding round?
The bridge round was led by Andrew Parker and Alfredo Vaamonde, co-founders of Papa.com, alongside participation from a Middle Eastern family office.

3. What does Mykare's AI platform do?
Mykare's AI-native healthcare operating system automates patient acquisition, appointment scheduling, voice interactions, CRM updates, feedback collection, and patient retention for hospitals and clinics.

4. Which countries does Mykare operate in?
Mykare currently operates across India, the United States, the United Kingdom, and the Middle East, with partnerships spanning oncology and dental healthcare providers.

5. Why is Mykare's funding significant?
The investment highlights growing global demand for AI-powered healthcare infrastructure and supports Mykare's expansion as India's healthtech market is projected to reach US$37 billion by 2030.